ARTICLE | Company News
BioTransplant, Miltenyi Biotec deal
June 9, 2003 7:00 AM UTC
BTRN is selling its Eligix HDM cell separation systems to Miltenyi for $450,000 plus 4%-10% royalties on future sales. The systems are used to treat B cell malignancies. BTRN, which has filed for Chap...